Co-Authors
This is a "connection" page, showing publications co-authored by James Brorson and Tareq Kass-Hout.
Connection Strength
2.568
-
Cost Effectiveness of Endovascular Thrombectomy for Large Ischemic Strokes: A US Healthcare Payer Markov Model Informed by Randomized Trials. Appl Health Econ Health Policy. 2026 07; 24(4):777-789.
Score: 0.242
-
Comparing validated stroke screening scales for identifying large and medium vessel occlusions: a prospective observational cohort study. J Neurointerv Surg. 2025 Nov 18; 17(12):1320-1324.
Score: 0.235
-
Comparative effectiveness of reduced dose Ticagrelor, full dose Ticagrelor, and Clopidogrel in acute stroke management. J Clin Neurosci. 2026 Jan; 143:111752.
Score: 0.235
-
Balloon guide catheter use for carotid body tumor embolization: A retrospective case series. Interv Neuroradiol. 2025 Jul 21; 15910199251359084.
Score: 0.230
-
Estimated Theoretical Benefit of Aggressive LDL Lowering in Patients With Symptomatic Intracranial Atherosclerosis. Neurology. 2025 Jul 08; 105(1):e213768.
Score: 0.228
-
Endovascular thrombectomy for distal medium vessel occlusions: A literature review. J Stroke Cerebrovasc Dis. 2025 Jan; 34(1):108134.
Score: 0.219
-
The Zoom RDL radial access system for neurointervention: An early single-center experience. J Neurointerv Surg. 2024 Feb 12; 16(3):266-271.
Score: 0.208
-
Intravenous cangrelor use for neuroendovascular procedures: a two-center experience and updated systematic review. Front Neurol. 2023; 14:1304599.
Score: 0.205
-
Endovascular Thrombectomy With or Without Thrombolysis for Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Neurohospitalist. 2024 Jan; 14(1):23-33.
Score: 0.202
-
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107227.
Score: 0.200
-
Endovascular thrombectomy with or without thrombolysis bridging in patients with acute ischaemic stroke: protocol for a systematic review, meta-analysis of randomised trials and cost-effectiveness analysis. BMJ Open. 2023 06 12; 13(6):e064322.
Score: 0.199
-
Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis. JAMA Netw Open. 2026 05 01; 9(5):e2610707.
Score: 0.061
-
Understanding the Relationship Between Cerebrovascular Disease and the Gut Microbiome. Stroke Vasc Interv Neurol. 2025 Jan; 5(1):e001272.
Score: 0.053
-
Real-World Outcomes for Basilar Artery Occlusion Thrombectomy With Mild Deficits: The National Inpatient Sample. Stroke. 2023 08; 54(8):2031-2039.
Score: 0.050